Joyn Bio is a joint venture founded to bring synthetic biology to the challenges of sustainability in agriculture, including engineering microbes that can provide plants with biological nitrogen fertilizer.
Timeline
March 2018
Joyn Bio raises a $100,000,000 series A round from Bayer, Ginkgo Bioworks and Viking Global Investors.
September 14, 2017
Joyn Bio raises a $100,000,000 series A round from Bayer, Ginkgo Bioworks and Viking Global Investors.
Funding rounds
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
References
Is a
CompanyCompany attributes
Industry
Biotechnology
Synthetic biologyLocation
BostonCompany status
Active
B2X
B2B
Jason Kelly
Reshma Shetty (entrepreneur)Legal name
Joyn Bio Inc.
Parent organization
BayerLegal classification
Incorporation (business)Number of Employees (ranges)
50 – 99
Full address
27 Drydock Ave Ste 8 Boston, MA, 02210-2383 United State
Viking Global Investors
Ginkgo BioworksTotal funding amount (USD)
200,000,000
Latest funding round date
March 2018
Board of Directors
Latest funding type
Series A round
